Accelerator Life Science Partners

About The Fund

Accelerator Life Science Partners is a venture capital firm that specializes as a startup studio with a focus on building and managing emerging biotechnology companies. With a strong presence established in 2003 in Seattle, Washington, their objective is to catalyze the development and commercialization of breakthrough biotechnology innovations. They engage in capital-efficient investment strategies and are adept at identifying, evaluating, financing, and managing commercially viable technologies and assets from a diverse range of proprietary sources. Their extensive set of start-up resources form a comprehensive business, scientific, and financial toolkit essential for operating a successful early-stage biotech company. As company builders, the experienced leaders at Accelerator Life Science Partners work hands-on with entrepreneurs to turn scientific discoveries into viable products, ensuring a clear and successful path to commercialization. By prioritizing cash flow, mitigating risks, defining processes, and focusing on catalyzing high-value returns, they prepare companies for their next stage of growth. The firm is known for its specialties in Seed, Startup, and Early Stage investments, with a commitment to mergers and equity financing. Holding $280 million in assets under management, they stand out for their unique approach to venture capital, reimagining the way partnerships are formed and nurtured in the life sciences sector. The fund's investment range is consistently set at $11 million, demonstrating their commitment to substantial and focused financial engagements with their portfolio companies. Accelerator Life Science Partners holds offices not only in Seattle but also in New York City, San Diego, and Singapore, showcasing their broad regional outreach and international influence.